Newsweek reports that cancer researchers are cautiously optimistic that they will soon be able to target mutant Ras.
British and foreign researchers brace for the effects of the UK leaving the EU, the Associated Press reports.
In PLOS this week: regulators of brown adipocyte differentiation, longevity and FOXO3 variants, and more.
NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.
New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.
Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.
In Science this week: genetic analysis of pollutant-tolerant fish, and more.
Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.
The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.
Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.
In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.
Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.
The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.
Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.
In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.
A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.
Canada begins its search for a chief government science advisor, Nature News reports.
After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.
In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.
Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.
In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.
Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.
In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.
Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.
Postdocs supported by external funding are less likely to have access to paid parental leave, Nature News reports.
The US National Institutes of Health's new plan will bolster support for early- and mid-career investigators.